Expression and Regulation of the PD-L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Objective-To evaluate the expression and regulation of a novel B7-like protein, PD-L1, the ligand for the immunoinhibitory receptor PD-1 expressed on activated T-cells, on microvascular endothelial cells (ECs) Methods-PD-L1 expression on ECs in vitro and in vivo was quantified by using a dual radiolabeled antibody technique after treatment with interferons (IFN) and IL-12, respectively.Changes in the level of PD-L1 mRNA were determined by using RT-PCR.Results-PD-L1 was observed to be present on ECs under basal conditions.Treatment of ECs with IFN-α, -β and -γ, but not LPS, was observed to induce elevations in the mRNA and surface expression of PD-L1 on ECs.By using a dual radiolabeled monoclonal antibody (mAb) technique, PD-L1 expression in various tissues of control and IL-12 challenged wild-type and IFN-γdeficient mice was measured.A significant increase in PD-L1 expression was observed in tissues at 24 hours after IL-12-challenge, with peak levels of PD-L1 occurring 72 hours after IL-12 challenge.IL-12 was not effective at inducing PD-L1 expression in tissues of IFN-γ-deficient mice.Conclusions-These data show the expression of a novel B7-like molecule on murine ECs that is mediated by IFN-α, -β, and -γ, and suggest a potential pathway by which ECs may modulate Tcell function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, endothelial cells can express PD-L1, which can further attenuate T cell function within the tumor microenvironment (Eppihimer et al., 2002).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Eppihimer et al., 2002
Citations
Cites
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Self-citationPD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Self-citationNishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758
Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., & Pober, J. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4342 · Cited by 472
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.861 · Cited by 469
Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice
Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., & Matthys, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5507 · Cited by 458
Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN- gamma .
Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E., & Carton, H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.5.1506 · Cited by 435
Hancock, W. W., Sayegh, M. H., Zheng, X.-G., Peach, R., Linsley, P. S., & Turka, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13967 · Cited by 411
Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse
Henninger, D. D., Panés, J., Eppihimer, M., Russell, J., Gerritsen, M., Anderson, D. C., & Granger, D. N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1825 · Cited by 347
Self-citationKNOLLE, P., SCHMITT, E., JIN, S., GERMANN, T., DUCHMANN, R., HEGENBARTH, S., GERKEN, G., & LOHSE, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70508-1 · Cited by 298
Signaling pathways activated by interferons
Platanias, L. C., & Fish, E. N. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00109-5 · Cited by 270
Regional differences in constitutive and induced ICAM-1 expression in vivo
Panes, J., Perry, M. A., Anderson, D. C., Manning, A., Leone, B., Cepinskas, G., Rosenbloom, C. L., Miyasaka, M., Kvietys, P. R., & Granger, D. N. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.6.h1955 · Cited by 241
Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells.
Epperson, D. E., & Pober, J. S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5402 · Cited by 155
Ma, W., & Pober, J. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2158 · Cited by 137
Marelli-Berg, F. M., Hargreaves, R. E., Carmichael, P., Dorling, A., Lombardi, G., & Lechler, R. I. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1603 · Cited by 122
Antigen Recognition Influences Transendothelial Migration of CD4+ T Cells
Marelli-Berg, F. M., Frasca, L., Weng, L., Lombardi, G., & Lechler, R. I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.696 · Cited by 106
Manual of Pharmacologic Calculations with Computer Programs.
Hill, I. D., Tallarida, R. J., & Murray, R. B. (1982) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2348009 · Cited by 93
Murray, A. G., Libby, P., & Pober, J. S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.151 · Cited by 74
Savage, C. O. S., Hughes, C. C. W., Pepinsky, R. B., Wallner, B. P., Freedman, A. S., & Pober, J. S. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90065-j · Cited by 61
Endothelial cell adhesion molecule expression in gene-targeted mice
Eppihimer, M. J., Russell, J., Anderson, D. C., Wolitzky, B. A., & Granger, D. N. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.4.h1903 · Cited by 57
Self-citationHuman endothelial cell costimulation of T cell IFN-gamma production
Briscoe, D. M., Henault, L. E., Geehan, C., Alexander, S. I., & Lichtman, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3247 · Cited by 56
Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production.
Kawashima, H., Prasad, S. A., & Gregerson, D. S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.5.1982 · Cited by 56
WILLIAMS, R. O., WILLIAMS, D. G., FELDMAISN, M., & MAINI, R. N. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb03399.x · Cited by 50
Marelli‐Berg, F. M., Scott, D. M., Bartok, I., Peek, E. J., Dyson, J., & Lechler, R. I. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4182 · Cited by 47
Jollow, K. C., Zimring, J. C., Sundstrom, J. B., & Ansari, A. A. (1999) · Transplantation · doi:10.1097/00007890-199908150-00016 · Cited by 38
Kawashima, H., & Gregerson, D. S. (1994) · Current Eye Research · doi:10.3109/02713689408999891 · Cited by 16
Differential Expression of Platelet-Endothelial Cell Adhesion Molecule-1 (PECAM-1) in Murine Tissues
Eppihimer, M. J., RUSELL, J. A. N. I. C. E., LANGLEY, R. O. B. E. R. T., VALLIEN, G., Anderson, D. C., & Granger, D. N. (1998) · Microcirculation · doi:10.1038/sj.mn.7300012 · Cited by 10
Self-citation[2] In vivo measurements of endothelial cell adhesion molecule expression
Eppihimer, M. J., & Granger, D. N. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)01064-2 · Cited by 9
Self-citation
Cited by
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Self-citationThe PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
Regulation and Function of the PD-L1 Checkpoint
Sun, C., Mezzadra, R., & Schumacher, T. N. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.014 · Cited by 2,193
The diverse functions of the PD1 inhibitory pathway
Sharpe, A. H., & Pauken, K. E. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.108 · Cited by 1,971
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Morad, G., Helmink, B. A., Sharma, P., & Wargo, J. A. (2021) · Cell · doi:10.1016/j.cell.2021.09.020 · Cited by 1,648
Metadata
- Authors
- Eppihimer, M., Gunn, J., Freeman, G., Greenfield, E., Chernova, T., Erickson, J., & Leonard, J.
- Affiliations
- Wyeth (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Eppihimer, Michael
- Venue
- Microcirculation
- Publisher
- Wiley
- Published
- 2002-04-01
- Volume
- 9
- Issue
- 2
- Pages
- 133-145
- ISSN
- 1073-9688 (ISSN-L)
- OpenAlex
- W4230040411
- Cited by
- 272
- References
- 29
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 4 · 2023: 12 · 2022: 11 · 2021: 21 · 2020: 18 · 2019: 17 · 2018: 18 · 2017: 23 · 2016: 20 · 2015: 9 · 2014: 7 · 2013: 15 · 2012: 8
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1 (tdm, 4901 d)
- Locations
- Microcirculation (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- PD-L1, microvascular endothelial cells, PD-1, interferon-gamma, interferon-alpha, interferon-beta, IL-12, T cell regulation, endothelial activation, IFN-gamma-deficient mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.